Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. sophomore Avg
|
New words:
Abbott, adequacy, admission, aforementioned, Allergan, amortizable, analyzing, carcinoma, ceiling, Columbia, comparison, consecutive, decade, deficit, disincentive, diversification, downturn, Dun, enable, euro, expedite, FDM, focusing, FOLFIRI, FOLFOX, House, inflated, intervene, Ireland, irinotecan, laherparepvec, landscape, language, Laoghaire, leader, Louisiana, magnify, malignant, MDL, myelosuppressive, Neugranin, Neulasta®and, originally, overview, pathological, pipeline, QIAGEN, reacquired, reconciled, reinterpreted, removal, residual, retrospectively, reversing, Ronald, SCCHN, solid, sooner, sort, spread, Streck, suit, surrogate, symptomatic, talimogene, unanticipated, underpay, unenforceable, unsealed, vote, Westmoreland, XGEVA®for, yearly
Filing tables
Filing exhibits
Related press release
AMGN similar filings
Filing view
External links